CELATOR PHARMACEUTICALS INC - 15089R102
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CAXTON CORP | History | No change | 2,246,469 | 7,121 | 5.44% | 5.44% | 1 | 0 | 0.0% | Q1 2014 | May 15, 2014 |
| SABBY MANAGEMENT, LLC | History | No change | 626,077 | 2,022 | 0.11% | 0.11% | 2 | 0 | 0.0% | Q1 2014 | May 14, 2014 |
| Opaleye Management Inc. | History | No change | 325,000 | 1,031 | 0.76% | 0.76% | 3 | 0 | 0.0% | Q1 2014 | May 15, 2014 |
| VANGUARD GROUP INC | History | Added to | 224,367 | 664 | 0.0% | 0.0% | 4 | +34,400 | 18.11% | Q2 2014 | Aug 11, 2014 |
| Alpha Cubed Investments, LLC | History | New | 32,092 | 95 | 0.04% | — | 5 | +32,092 | New | Q2 2014 | Jul 21, 2014 |
| HAMILTON LANE ADVISORS LLC | History | New | 17,280 | 51 | 0.02% | — | 6 | +17,280 | New | Q2 2014 | Jul 02, 2014 |
| Concept Capital Markets, LLC | History | Reduced | 12,000 | 36 | 0.01% | 0.02% | 7 | -750 | -5.88% | Q2 2014 | Aug 08, 2014 |
| UBS AG | History | No change | 3,045 | 10 | 0.0% | 0.0% | 8 | 0 | 0.0% | Q1 2014 | May 16, 2014 |
| MORGAN STANLEY | History | No change | 44 | 0 | — | — | — | 0 | 0.0% | Q1 2014 | May 13, 2014 |